Joseph MBA - Bonus Biogroup Ex Chairman

BONS Stock  ILS 10.80  0.10  0.93%   

Insider

Joseph MBA is Ex Chairman of Bonus Biogroup
Age 66
Phone972 7 320 67104
Webhttps://www.bonusbiogroup.com

Bonus Biogroup Management Efficiency

The company has return on total asset (ROA) of (0.0636) % which means that it has lost $0.0636 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5522) %, meaning that it generated substantial loss on money invested by shareholders. Bonus Biogroup's management efficiency ratios could be used to measure how well Bonus Biogroup manages its routine affairs as well as how well it operates its assets and liabilities.
Bonus Biogroup has accumulated 6.28 M in total debt. Bonus Biogroup has a current ratio of 0.34, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Bonus Biogroup until it has trouble settling it off, either with new capital or with free cash flow. So, Bonus Biogroup's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Bonus Biogroup sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Bonus to invest in growth at high rates of return. When we think about Bonus Biogroup's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Yaackov NadbornyB Communications
58
Liza TavoriOrmat Technologies
N/A
David RadolskyNrgene Technologies
38
Kobi BaruchNrgene Technologies
47
Yaniv SalomonB Communications
N/A
Tomer RavedB Communications
38
Ofer BenyosefOrmat Technologies
59
Jessica WoelfelOrmat Technologies
46
Yana VoldmanNrgene Technologies
N/A
Lital AharoniB Communications
N/A
Noam BarkaiNrgene Technologies
48
Danny HaklaiTedea Technological Development
68
Yaakov BaruchNrgene Technologies
47
Assaf GinzburgOrmat Technologies
48
Yael EfronTedea Technological Development
74
Tali YaronEldarTedea Technological Development
55
Ehud BelderNrgene Technologies
39
Gil RonenNrgene Technologies
55
Itai MordoTedea Technological Development
N/A
Ilan ChaikinB Communications
69
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd., formerly known as Oceana Advanced Industries Ltd., was founded in 1981 and is based in Haifa, Israel. BONUS BIOGROUP is traded on Tel Aviv Stock Exchange in Israel. Bonus Biogroup (BONS) is traded on Tel Aviv Stock Exchange in Israel and employs 13 people.

Management Performance

Bonus Biogroup Leadership Team

Elected by the shareholders, the Bonus Biogroup's board of directors comprises two types of representatives: Bonus Biogroup inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bonus. The board's role is to monitor Bonus Biogroup's management team and ensure that shareholders' interests are well served. Bonus Biogroup's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bonus Biogroup's outside directors are responsible for providing unbiased perspectives on the board's policies.
Joseph MBA, Ex Chairman
Vered Kivity, Head Affairs
Shai Meretzki, CEO and Presidentident, Director
Yoni CPA, Chief Officer

Bonus Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bonus Biogroup a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Bonus Stock

Bonus Biogroup financial ratios help investors to determine whether Bonus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus Biogroup security.